Skip to main content
Heritage Bio Labs · Research use only
Heritage Bio Labs

GLP-2 TIRZCheck methods and identity

How SURMOUNT-MAINTAIN tested weight maintenance

2 numbered sourcesSource years 2022, 2026

Peptides are short amino-acid chains held together by peptide bonds. A modified peptide can activate receptors involved in how the body handles meals. Tirzepatide activates GIP and GLP-1 receptors. In “GLP-2 TIRZ,” the GLP-2 wording is a catalog identifier. The SURMOUNT-MAINTAIN trial examined what happened to body weight after adults had already taken tirzepatide during an initial weight-loss phase. [1, 2]

The trial had two periods. In the first, everyone who entered the treatment period received tirzepatide. After 60 weeks, 378 participants were randomized to continue the same assigned intensity, receive a lower study strength, or switch to placebo for another 52 weeks. The three-way comparison addressed maintenance in people who reached randomization after the initial period. The result describes that group. People who stopped during the initial period or never entered it were not part of the randomized maintenance comparison. [1]

At week 112, estimated average weight was 21.9% below the original baseline in the group that continued at the prior intensity, 16.6% below baseline in the lower-strength group, and 9.9% below baseline in the group that switched to placebo. The numbers refer to the beginning of the whole study. They are not percentages lost after week 60. Measuring from the original baseline allowed investigators to see how much of the initial reduction remained by the end of follow-up. [1]

The protocol also allowed people with substantial regain during maintenance to receive a rescue intervention under defined conditions. The main analysis included randomized participants and used prespecified assumptions to handle rescue treatment. Those decisions affect what the final estimates represent. It is useful to keep the entire sequence of the study in mind before comparing its results with a trial where participants were assigned to a treatment at the outset. [1]

The findings separate initial weight change from its maintenance in the same research program. The study provides evidence about the tested assignments and duration. It does not determine a future weight trajectory for any individual or establish what would happen after a longer follow-up. The different average results show why maintenance is a question that calls for its own comparison and measurements. [1]

Sources

Original works cited in this article. Links open the external record in a new tab.

Shop GLP-2 TIRZ

Articles from the Heritage Bio Labs research series, with links to the original sources. For research use only; not medical advice. Also available as Markdown or JSON.